240 related articles for article (PubMed ID: 27471391)
1. Matrix metalloproteinases in exercise and obesity.
Jaoude J; Koh Y
Vasc Health Risk Manag; 2016; 12():287-95. PubMed ID: 27471391
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and their inhibitors.
Kugler A
Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
[TBL] [Abstract][Full Text] [Related]
3. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
[TBL] [Abstract][Full Text] [Related]
4. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
[TBL] [Abstract][Full Text] [Related]
5. Variations on brain microglial gene expression of MMPs, RECK, and TIMPs in inflammatory and non-inflammatory diseases in dogs.
Stein VM; Puff C; Genini S; Contioso VB; Baumgärtner W; Tipold A
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):17-26. PubMed ID: 21802747
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G
J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
8. Basic calcium phosphate crystals up-regulate metalloproteinases but down-regulate tissue inhibitor of metalloproteinase-1 and -2 in human fibroblasts.
Bai G; Howell DS; Howard GA; Roos BA; Cheung HS
Osteoarthritis Cartilage; 2001 Jul; 9(5):416-22. PubMed ID: 11467889
[TBL] [Abstract][Full Text] [Related]
9. The expression of human corneal MMP-2, MMP-9, proMMP-13 and TIMP-1 in bullous keratopathy and keratoconus.
Predović J; Balog T; Marotti T; Gabrić N; Bohac M; Romac I; Dekaris I
Coll Antropol; 2008 Oct; 32 Suppl 2():15-9. PubMed ID: 19138000
[TBL] [Abstract][Full Text] [Related]
10. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
[TBL] [Abstract][Full Text] [Related]
11. Prolactin Protects the Structural Integrity of Human Fetal Membranes by Downregulating Inflammation-induced Secretion of Matrix Metalloproteinases.
Flores-Espinosa P; Olmos-Ortíz A; Granados-Cepeda M; Quesada-Reyna B; Vega-Sánchez R; Velázquez P; Zaga-Clavellina V
Immunol Invest; 2022 Jul; 51(5):1313-1329. PubMed ID: 34132165
[TBL] [Abstract][Full Text] [Related]
12. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
[TBL] [Abstract][Full Text] [Related]
13. Circulating and adipose tissue matrix metalloproteinases in cardiometabolic risk environments: pathophysiological aspects.
Berg G; Schreier L; Miksztowicz V
Horm Mol Biol Clin Investig; 2014 Feb; 17(2):79-87. PubMed ID: 25372732
[TBL] [Abstract][Full Text] [Related]
14. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
15. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats.
Schaefer L; Han X; August C; Matzkies F; Lorenz T; Schaefer RM
Diabetologia; 1997 Sep; 40(9):1035-43. PubMed ID: 9300240
[TBL] [Abstract][Full Text] [Related]
17. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
18. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase by myofibroblasts--morphological study on corneal wound healing].
Shimoda M; Ishizaki M; Saiga T; Yamanaka N
Nippon Ganka Gakkai Zasshi; 1997 May; 101(5):371-9. PubMed ID: 9170840
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
Sugiura Y; Shimada H; Seeger RC; Laug WE; DeClerck YA
Cancer Res; 1998 May; 58(10):2209-16. PubMed ID: 9605768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]